Works matching IS 17530393 AND DT 2024 AND VI 16 AND IP 4


Results: 22
    1

    The 2023 WCIRDC: Obesity.

    Published in:
    Journal of Diabetes, 2024, v. 16, n. 4, p. 1, doi. 10.1111/1753-0407.13568
    By:
    • Bloomgarden, Zachary T.
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20

    Efficacy and safety of bexagliflozin compared with dapagliflozin as an adjunct to metformin in Chinese patients with type 2 diabetes mellitus: A 24‐week, randomized, double‐blind, active‐controlled, phase 3 trial.

    Published in:
    Journal of Diabetes, 2024, v. 16, n. 4, p. 1, doi. 10.1111/1753-0407.13526
    By:
    • Xie, Lingding;
    • Han, Jie;
    • Cheng, Zhifeng;
    • Liu, Dexue;
    • Liu, Jie;
    • Xu, Chunrong;
    • Sun, Wenli;
    • Li, Qingju;
    • Bian, Fang;
    • Zhang, Wei;
    • Chen, Jinyu;
    • Zhu, Qian;
    • Thurber, Tara K.;
    • Lock, J. Paul;
    • Zhang, Bo
    Publication type:
    Article
    21
    22

    Issue Information.

    Published in:
    Journal of Diabetes, 2024, v. 16, n. 4, p. 1, doi. 10.1111/1753-0407.13417
    Publication type:
    Article